ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 141 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,415,000 | -46.6% | 75,000 | -66.7% | 0.00% | 0.0% |
Q2 2019 | $2,649,000 | +158.7% | 225,000 | +200.0% | 0.00% | 0.0% |
Q1 2019 | $1,024,000 | +33.2% | 75,000 | 0.0% | 0.00% | +100.0% |
Q4 2018 | $769,000 | -38.4% | 75,000 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $1,249,000 | +5.4% | 75,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $1,185,000 | +24.3% | 75,000 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $953,000 | +9.7% | 75,000 | -1.2% | 0.00% | 0.0% |
Q4 2017 | $869,000 | -5.4% | 75,900 | +1.2% | 0.00% | 0.0% |
Q3 2017 | $919,000 | +7.0% | 75,000 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $859,000 | -79.6% | 75,000 | -63.0% | 0.00% | -75.0% |
Q1 2017 | $4,214,000 | +44.2% | 202,613 | +44.2% | 0.01% | +33.3% |
Q4 2016 | $2,922,000 | -11.3% | 140,489 | +39.8% | 0.01% | 0.0% |
Q3 2016 | $3,293,000 | -34.4% | 100,489 | -50.0% | 0.01% | +20.0% |
Q2 2016 | $5,016,000 | +192.6% | 200,900 | +187.0% | 0.01% | +66.7% |
Q1 2016 | $1,714,000 | – | 70,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |